Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review-Reference-Cited by-同舟云学术

Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review

Published:2016-12-09 Issue:2 Volume:47 Page:271-293
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Farzan N.¹²,Vijverberg S. J. H.¹²,Arets H. G.³,Raaijmakers J. A. M.¹,Maitland-van der Zee A. H.¹²

Affiliation:

1. Division of Pharmacoepidemiology & Clinical Pharmacology; Utrecht Institute for Pharmaceutical Sciences; Utrecht University; Utrecht the Netherlands

2. Department of Respiratory Medicine; Academic Medical Center (AMC); University of Amsterdam; Amsterdam the Netherlands

3. Department of Paediatric Pulmonology; University Medical Centre Utrecht; Utrecht the Netherlands

Funder

Stichting Astma Bestrijding

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12844/fullpdf

Reference93 articles.

1. Global Initiative for Asthma (GINA) From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2015 http://www.ginasthma.org/

2. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma;Szefler;J Allergy Clin Immunol,2005

3. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group;Malmstrom;Ann Intern Med,1999

4. Heterogeneity of therapeutic responses in asthma;Drazen;Br Med Bull,2000

5. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society;Chung;Eur Respir J,1999

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SingleNucleotide Polymorphisms as Biomarkers of Mepolizumab and Benralizumab Treatment Response in Severe Eosinophilic Asthma;International Journal of Molecular Sciences;2024-07-26

2. Advances in Genome-Wide Association Study on Asthma Pharmacogenomics;Advances in Clinical Medicine;2024

3. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs;Nature Reviews Drug Discovery;2023-08-01

4. Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022;Breathe;2023-06

5. Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype;International Journal of Molecular Sciences;2023-04-10